This is a default text for your page '. Click above on edit this page' to modify. Be careful with the < and > signs.
You may include any references to papers as in: the use of JSmol in Proteopedia [1] or to the article describing Jmol [2] to the rescue.
Function
4iv6 functions were not studied and only structural infos are disponible.
Nevertheless we can consider datas from other E.C.1.3.8.1[1] which came from other organisms.
Butyryl-CoA Dehydrogenase[2].
Primary and Secondary structure[3]
Isovaleryl-CoA dehydrogenase is the assembly of each composed of two chains and linked by a (Dihydroflavine-Adenine Dinucleotide also known as FADH2 ). Each of the two chains A and B are composed of 388 amino acids. An asymmetric unit is therefore composed of 776 amino acids and has a molecular weight of 86233.70 Da.
The A chain is made up of (involving 221 residues) and (61 residues).
Chain B is formed of (involving 218 residues) and (62 residues).
Tertiary structures
Enzyme accepted name: Short-chain acyl-CoA dehydrogenase
Other names:Butanoyl-CoA dehydrogenase, Butyryl dehydrogenase, Short-chain acyl CoA dehydrogenase, Unsatured acyl-CoA reductase.
Enzyme class: E.C.1.3.8.1[3]
Substrate: A short-chain acyl CoA
Prosthetic group: 1 electron-transfer flavoprotein such as FDA, for every Subunits
Products: a short-chain trans-2,3-dehydroacyl-CoA + reduced electron-transfer flavoprotein
Informed Pathways: Fatty acid degradation
Other information:
The enzyme from beef liver can accept acyl-chain lengths from 3 to 8 carbon atoms. From different organism the range can vary so we ignore if M.tuberculosis gets the same lengths resolution.
The highest activity reported for beef liver enzyme was for substrates with 4 and 5 carbon acyl-chain lengths.
4IV6 as a research tool
4iv6 which belong to Mycobacterium tuberculosis was studied with other protein homolog.
They were chosen to be studied as potential TB-Drugs target
Studies have been made on homolog similarities aimed on their active site because with the knowledges of many homolog active site structure and how they work, we can design a inhibitor of those enzyme which can stop essential reaction and reduce or stop M.tuberculosis infection.
This strategy is called an « Homolog-rescue strategy ».
This strategy can be generalized for other drug target for other diseases.
Structural highlights summary
